Health Condition 1: K759- Inflammatory liver disease, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. NAFLD diagnosis made by detecting liver steatosis on fibro scan with score of steatoses i.e. controlled attenuation parameter (CAP) = 238 dB/m i.e. 11-33% fatty change in the liver. 2. Patients who are between the ages of 18 to 65 years. 3. Absence of significant alcohol consumption ( 4. Elevated Serum liver enzymes, Lipid profile and plasma glucose and insulin concentrations
Exclusion criteria
Exclusion criteria: 1. The surrogate scores of liver stiffness (LSM) which can be in line with stage 4 fibrosis/cirrhosis = 11 kPa. 2. Uncontrolled diabetes history (HbA1c > 9%) 3. Uncontrolled hypertension 4. Diagnosed cases of disease-preventing administration to aerobic exercise; cardiovascular, neurological, orthopedics disease history. 5. Diagnosed cases of viral hepatitis, autoimmune liver disease, hemochromatosis, or drug-induced hepatotoxicity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fibro scan- Transient elastography will be performed using the Fibro scan according to a standardized protocol Liver function test- Liver function test will be made in an internationally accredited laboratory, using standard methodsTimepoint: 1st- Beginning of intervention 2nd- at the end of 12 weeks of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Anthropometric MeasurementsTimepoint: 1st- beginning of intervention 2nd- At the end of 12 weeks of intervention | — |
Countries
India
Contacts
KLE Institute of physiotherapy